US Initiates Marijuana Reclassification, Biden Advocates Reform

Web DeskJune 23, 2024 10:25 AMpolitics
  • Marijuana downgraded to Schedule III, indicating low dependence potential
  • States like Maryland, Massachusetts, Oregon rectifying past marijuana convictions
  • US shifting towards more equitable and compassionate drug regulation
US Initiates Marijuana Reclassification, Biden Advocates ReformImage Credits: channelnewsasia
The United States is reclassifying marijuana to Schedule III, reflecting a shift towards more humane drug policies. President Biden advocates for reform and pardons individuals with marijuana-related convictions.

In a significant development, the United States has initiated steps to reclassify marijuana, a move that could have far-reaching implications. Marijuana, which has long been classified as a Schedule I drug alongside substances like heroin and LSD, is now set to be downgraded to a Schedule III drug. This shift places marijuana in a category with drugs like testosterone and certain painkillers, indicating a 'moderate to low potential' for dependence.

This decision comes after years of debate and growing recognition of the need for reform in drug policies. US President Joe Biden has been vocal about the need to address the injustices caused by strict marijuana laws. He has emphasized that individuals should not face imprisonment for using or possessing marijuana, signaling a more progressive approach to drug regulation.

As part of this reform, several states, including Maryland, Massachusetts, and Oregon, have taken steps to rectify past convictions related to marijuana. Maryland, for instance, recently pardoned over 175,000 individuals with marijuana-related convictions, highlighting a broader trend towards decriminalization and social justice.

The reclassification of marijuana in the United States marks a significant shift in drug policy, reflecting a growing understanding of the need for more balanced and humane approaches to substance use. By acknowledging the failures of past policies and taking concrete steps towards reform, the US is paving the way for a more equitable and compassionate approach to drug regulation.

Related Post